BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 17471086)

  • 21. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
    Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
    Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
    Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
    Schimandle JH; Boden SD; Hutton WC
    Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells expressing baculovirus-engineered BMP-2 and VEGF enhance posterolateral spine fusion in a rabbit model.
    Fu TS; Chang YH; Wong CB; Wang IC; Tsai TT; Lai PL; Chen LH; Chen WJ
    Spine J; 2015 Sep; 15(9):2036-44. PubMed ID: 25463976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
    J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
    Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
    Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrow-derived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion.
    Abbah SA; Lam CX; Ramruttun AK; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2011 Oct; 36(21):1752-9. PubMed ID: 21673630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area.
    Ames CP; Smith JS; Preul MC; Crawford NR; Kim GE; Nottmeier E; Chamberlain R; Speiser B; Sonntag VK; Dickman CA
    Spine (Phila Pa 1976); 2005 Dec; 30(23):2585-92. PubMed ID: 16319743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
    Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
    J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental research on spinal fusion with recombinant human bone morphogenetic protein-2 and bone marrow stromal cell composited tricalcium phosphate (TCP)].
    Yang X; Wu L; Fang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1156-9, 1167. PubMed ID: 23469548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
    Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
    Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion.
    Grauer JN; Patel TC; Erulkar JS; Troiano NW; Panjabi MM; Friedlaender GE
    Spine (Phila Pa 1976); 2001 Jan; 26(2):127-33. PubMed ID: 11154530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2.
    Morone MA; Boden SD; Hair G; Martin GJ; Racine M; Titus L; Hutton WC
    Clin Orthop Relat Res; 1998 Jun; (351):252-65. PubMed ID: 9646769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.